ARLINGTON, VA – As some Medicare Advantage plans and Medicaid programs shift coverage of Continuous Glucose Monitors (CGM) therapy and related supplies to the pharmacy channel, AAHomecare developed new turnkey resources to help diabetes-focused DME suppliers demonstrate the value of prescribing CGM therapy through the DME channel.

These resources are designed to support conversations with referral sources and Certified Diabetes Educators, reinforcing the critical role of DME supplies in improving access, support, and adherence.

“These resources give suppliers a professional, consistent way to engage with clinicians and show them that DME suppliers are more than product providers – we’re partners in patient success,” explains Linda Langiotti, senior VP, Strategic Channels at CCS Medical and chair of AAHomecare’s Diabetes Council. “Starting a new therapy is challenging for many patients. It’s critical that clinicians understand the difference DME suppliers make helping patients thrive on CGM therapy.”

The new resources are tailored to two key audiences:

• Referral Sources (endocrinologists and primary care physicians) – Highlights how partnering with suppliers reduce office burden, streamline referrals, and provide stronger onboarding and ongoing support. (Available here)
• Certified Diabetes Educators – Emphasizes how suppliers reinforce training, ensuring continuity of therapy and providing real-world support that empowers end users to succeed with CGM therapy. (Available ere)

Together, these tools strengthen the supplier-clinician relationships and provide HME stakeholders with a unified, credible way to communicate the benefits of the DME channel.

Recent data reinforces this value: people with diabetes served DME suppliers demonstrated higher adherence rates and better continuity of care compared to those accessing through other channels according to this study.  Additionally, 73% of endocrinologists reported preferring DME suppliers over other distribution models because of the superior support provided to end users.

“These resources help the HME community show clinicians and educators how DME suppliers provide specialized support, helping ensure people with diabetes achieve the best outcomes while highlighting the importance of preserving the DME channel,” notes David Chandler, vice president, Payer Relations at AAHomecare. “By reinforcing the value of supplier-led care at the practice level, they also strengthen our ongoing advocacy to protect access to CGM therapy through suppliers.”

AAHomecare has been instrumental in safeguarding patient access to CGM therapy through the DME channel, including recent advocacy wins in Arizona (SB 1132) and Arkansas (Act 857). The new resources mark another step in ensuring that clinicians and educators recognize the indispensable role of DME suppliers in diabetes management.

Find links to the resources here along with more about AAHomecare’s CGM channel advocacy.